Clinical Trial Update: Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated dose-dense fluorouracil regimens (FU 75 and FU 90) as adjuvant therapy for early breast cancer and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)

Snippet

Sponsor: Central European Cooperative Oncology Group | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED